Physician profile
Wayne H Senft
NPI 1861554172
$2,138.22
in general payments reported to CMS, 2019-2025
9 companies · $45.39 in 2025
The $45.39 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2021: $539 · 2022: $827 · 2023: $170 · 2024: $260 · 2025: $45.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,160.49 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $238.16 | 2019-2024 | Eliquis |
| Glaxosmithkline, LLC. | $194.69 | 2024-2025 | Arexvy |
| Astrazeneca Pharmaceuticals Lp | $186.69 | 2021-2022 | |
| Exact Sciences Corporation | $109.65 | 2023 | Cologuard Collection Kit |
| Neurelis, INC. | $99.20 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $70.03 | 2022 | |
| Phathom Pharmaceuticals, INC. | $65.65 | 2024 | Voquezna |
| Pfizer INC. | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Senft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.